MCCLEAN, VA, UNITED STATES, December 16, 2024 /EINPresswire / -- Perthera, the leader in AI-driven Precision Oncology Decision Support, has unveile ...
It uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line treatments have ...
On the morning of December 12, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San ...
Patients with heavily pretreated microsatellite stable metastatic colorectal cancer (CRC) had survival benefits after using ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
On the morning of2, 2024 (UTC-6), at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS), RemeGen Co. Ltd. ("RemeGen") (9995.HK, 688331.SH) ...
RemeGen’s Phase III trial of disitamab vedotin shows improved progression-free survival in advanced breast cancer patients ...
MALMO, SWEDEN / ACCESSWIRE / December 17, 2024 / Ascelia Pharma (STO:ACE), a biotech focused on improving the life of people living with rare cancer conditions, today announced that two scientific abs ...
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
India Today on MSN4d
Worry about the genes you inherit, not property: Liver specialist Dr SK SarinHepatologist Dr SK Sarin, speaking at Agenda AajTak, urged people to look for inherited diseases and not wealth to assess a ...
Liam Handley, 36, visited his GP in 2020 when he experienced worsening chest pains which were dismissed as stress and anxiety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback